One of the scariest things about COVID-19 was the vast amount of information out there — much of it inaccurate. Dr. Shirin Mazumder, an infectious diseases physician at Methodist Le Bonheur Healthcare, set the record straight. In 2021, she started delivering reports weekly on WMC Action News 5, updating viewers on Centers for Disease Control (CDC)… Read More
Ascension Saint Thomas and the University of Tennessee Health Science Center launched a first of its kind: a program to get more doctors into rural communities.
The University of Tennessee Health Science Center’s Campus Cupboard received a $1,400 donation in supplies from initiated members of the Alcorn State University Delta Epsilon chapter of Delta Sigma Theta Sorority, Inc. during their recent Reunion Service Day in Memphis.
Ascension Saint Thomas and the University of Tennessee Health Science Center launched a first of its kind: a program to get more doctors into rural communities.
Memphis could be in for a rough flu season, fueled by decreased immunity, an early spike in respiratory illnesses and low vaccination rates, according to infectious disease experts. “So the concern is that we’re going to have a more substantial flu season — certainly more severe than what we’ve seen the past couple of years,”… Read More
Art of Science is an exhibit at Crosstown Concourse that explores the science that medical researches work with everyday to save lives. This exhibit is a partnership between Crosstown Concourse, LeBonheur Children’s Hospital, and the University of Tennessee Health Science Center.
The mission of The Plough Center for Sterile Drug Delivery Solutions is to help patients by expediting efforts to bring innovative, life-saving medicines to market. The Plough Center is a US-FDA registered cGMP sterile drug manufacturing facility owned by the University of Tennessee Health Science Center in Memphis. Plough assists universities, scientific communities, and the pharmaceutical… Read More
According to Coherent Market Insights, the global chronic kidney disease drugs market is estimated to be valued at US$ 13,220.0 million in 2022 and is expected to exhibit a CAGR of 4.5% during the forecast period (2022-2030). Increasing prevalence of chronic kidney disease is expected to drive the growth of the global chronic kidney disease drugs market. For instance, according to an article published by the University of Tennessee Health… Read More
